About Us


Cardiobase was founded in 1989 and we have been supporting customers ever since.

Our founder, Barry Pate, noticed that as technology evolved, so did modern health requirements. He founded Cardiobase on two key principles, grow with your customers and offer best-in-class support.

Initially, Cardiobase was a computerised pacemaker implant register and follow-up system. However, as time went on, there was a need to further support Cardiology departments with technical solutions.

In 2016, Cardiobase shifted focus from being a software company to a solutions company. Our objective is to ensure that the end-to-end client outcomes are achieved rather than providing an one-size-fits-all software.

While leading software will always be at the core of Cardiobase, we recognise the major challenges in the industry and consequently Cardiobase has adapted to offer a solution that comes with a full range of support, integration and analytical services to ensure that customers are able to realise the full benefits of an integrated solution.

Our growing customer support and development team, based in Australia and the UK , is bringing better and effective product delivery to our customers whilst gaining a greater understanding of our client’s real needs and how we can help them.

This enables our customers to be fully supported and allowing them to focus their time and energy on delivering top quality patient care.

Cardiobase is now in over 5 countries and has provided over 400,000 patient outcomes annually.

Leading Technology Group

In 2015, Leading Technology Group acquired a controlling interest in Cardiobase. The aligned mission of closely supporting healthcare, made Cardiobase an ideal acquisition for Leading Technology Group.

Leading Technology Group is an investment company with a primary focus on service and technology businesses in the life sciences and health industries.  

Cardiobase is proud to be a part of the Leading Technology Group, and together we share the same vision to deliver solutions that improve healthcare outcomes for patients globally.